Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
very engaged, close to the employees
Quelle est la meilleure partie de votre programme de rémunération?
annual bonus is fairly distributed
Quelles sont les meilleures choses à propos de votre équipe?
team members are knowledgeable and we help each other
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
the thinking and all the activities are for the patients
Qu’est-ce qui vous rend le plus heureux au travail?
I have got the opportunity to be involved in the development of the drug until market approval
Other Employee Reviews for Karyopharm Therapeutics
×